News | December 23, 2010

Dilon - BSGI with the Dilon 6800 Gamma Camera

Dilon - BSGI with the Dilon 6800 Gamma Camera

Dilon Diagnostics provides a complete system for breast-specific gamma imaging (BSGI) and biopsy guidance. The Dilon 6800 gamma camera supports the diagnostic procedure of molecular breast imaging, known as BSGI or MBI, with high-resolution digital imaging optimized for early breast cancer detection.

BSGI/MBI with the Dilon 6800 captures vital tumor information by viewing the metabolism of lesions in the breast via radiopharmaceutical uptake. It can detect early stage cancers, see lesions independent of tissue density and is capable of providing the same views as mammography; thereby providing physiological data in images that directly correlate to the mammogram.

BSGI with the Dilon 6800 is an ideal complement to mammography and is indicated for:
• Challenging diagnostic workups;
• provides very high sensitivity for detecting DCIS, lobular carcinoma and small non-palpable lesions;
• high-risk patients, particularly with dense breast tissue;
• determining the extent of disease, and
• pre-surgical planning.

GammaL?c — Localization for Gamma-Guided Biopsy
Dilon Diagnostics offers BSGI/MBI systems and is the only company with an FDA-cleared biopsy solution for gamma-guided localization. GammaL?c is an accessory to the Dilon 6800 that helps physicians accurately locate lesions to perform biopsies of suspicious regions found with BSGI.

Clinical Data
One of several recent studies presented at the Radiological Society of North America (RSNA) 96th Annual Meeting on BSGI reported it to be a valuable tool for detecting breast cancer, particularly for women who are at increased risk for the disease or have dense breast tissue. Barbara H. Ward, M.D., and associates of Weinstein Imaging in Pittsburgh noted in the study that BSGI displayed a higher sensitivity for detecting cancerous lesions than mammography or ultrasound.

SNM Guidelines for Breast Scintigraphy with Breast-Specific Gamma Cameras
The Society of Nuclear Medicine has issued guidelines for practitioners in selecting patients, performing, interpreting and reporting for 99mTc-sestamibi breast-specific gamma imaging.

Online continuing medical education credits for BSGI are available through WebMedEd via access code BSGI1001C at The course provides for two AMA/PRA Category 1 CME credits.

For more information:


Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
The MOZART Supra Specimen Tomosynthesis System is the latest generation of 3-D imaging for breast cancer surgery.
News | Breast Imaging | November 08, 2018
KUBTEC announced the launch of a new innovation in the treatment of breast cancer. The Mozart Supra Specimen...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
Charles Ananian, M.D.

Charles Ananian, M.D.

Sponsored Content | Case Study | Digital Radiography (DR) | November 07, 2018
Whether it’s a premature baby or a critically ill child, treating little patients is a huge responsibility.
Feature | Breast Imaging | November 07, 2018 | By Jeff Zagoudis
Breast imaging technology has experienced major growth over the last decade or so, and a new report suggests the mark
Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Results of the vertebrae-based analysis (383 vertebrae in 34 patients) for detection of BME.

Sponsored Content | Case Study | Computed Tomography (CT) | November 06, 2018
The following is a summary of a study published in the
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages